Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (February 2023)

10 February 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 27 January 2023.  ...

Read more →

Public Summary Documents – September 2022 PBAC meeting

13 January 2023 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the September 2022 PBAC ...

Read more →

Final report for the post-market review of medicines for smoking cessation and review outcomes

22 December 2022 - The final report for the post-market review of medicines for smoking cessation is now available. The ...

Read more →

PBS Expenditure and Prescriptions Report (2021-22)

21 December 2022 - The PBS Expenditure and Prescriptions Report 1 July 2021 to 30 June 2022 is now available. ...

Read more →

PBAC Public Summary Document (November 2022)

18 November 2022 - The Public Summary Documents for the Review of the base-case discount rate in the PBAC Guidelines from ...

Read more →

Public Summary Documents (first time decisions not to recommend and deferrals) - July 2022 PBAC meeting

11 November 2022 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the July 2022 PBAC ...

Read more →

Outcome statement - September 2022 DUSC meeting

3 November 2022 - The outcome statement from the September 2022 DUSC meeting is now available. ...

Read more →

Public Summary Documents – July 2022 PBAC meeting

28 October 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2022 PBAC ...

Read more →

DUSC utilisation analysis public release documents (October 2022)

25 October 2022 - The utilisation analysis public release documents from the June 2022 DUSC meeting are now available. ...

Read more →

PBAC Public Summary Documents (first time rejections and deferrals) - May 2022 meeting

9 September 2022 - The Public Summary Documents (first time rejections and deferrals) from the May 2022 PBAC meeting are now ...

Read more →

Review of Efficient Funding of Chemotherapy Program - interim report

5 September 2022 - The Efficient Funding of Chemotherapy review seeks to investigate current processes involved in the production, distribution ...

Read more →

PBAC Public Summary Documents – May 2022 meeting

26 August 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2022 PBAC ...

Read more →

2022-2023 cost recovery implementation statement

12 August 2022 - The 2022-23 PBS and NIP cost recovery implementation statement is now available.  ...

Read more →

PBAC Public Summary Documents (first time rejections and deferrals) – March 2022 meeting

15 July 2022 - The Public Summary Documents (first time rejections and deferrals) from the March 2022 PBAC meeting are now ...

Read more →

Drug Utilisation SubCommittee outcome statement

8 July 2022 - The outcome statement from the June 2022 DUSC meeting is now available. ...

Read more →